跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TERRYWHITE CHEMMART IBUPROFEN SODIUM ibuprofen sodium dihydrate 256mg tablet blister pack new formulation 2 - TGA Drug Approval Details
Approvals
/
TGA
/
TERRYWHITE CHEMMART IBUPROFEN SODIUM ibuprofen sodium dihydrate 256mg tablet blister pack new formulation 2
Approved
STANDARD
TERRYWHITE CHEMMART IBUPROFEN SODIUM ibuprofen sodium dihydrate 256mg tablet blister pack new formulation 2
NOUMED PHARMACEUTICALS PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
4b16159a68cf6ecc
Company
NOUMED PHARMACEUTICALS PTY LTD
Type
Standard
Approval Details
Approval Id
4b16159a68cf6ecc
Product Name
TERRYWHITE CHEMMART IBUPROFEN SODIUM ibuprofen sodium dihydrate 256mg tablet blister pack new formulation 2
Artg Id
465327
Artg Name
TERRYWHITE CHEMMART IBUPROFEN SODIUM ibuprofen sodium dihydrate 256mg tablet blister pack new formulation 2
Sponsor
NOUMED PHARMACEUTICALS PTY LTD
Company Detail Path
/organization/noumed-pharmaceuticals-pty-ltd
Artg Date
2024-10-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
4b16159a68cf6ecc
Type
Standard
Back to TGA Approvals
